Gyana Announces Sale of Breakthrough Big Data Platform NEERA

Gyana CEO and CTO

NEERA, a groundbreaking “human mobility data” platform previously used by Barclays, Pret, UK MoD, and others has been acquired by Fetch Capital Partners.

Gyana, an award-winning big data and AI startup based in London, UK, has announced that it has completed the sale of its cutting-edge “human mobility data” platform NEERA.

The platform provides businesses across multiple verticals ranging from retail to finance and real estate the means to parse footfall and other geospatial and human mobility data, affording businesses unique insight on which to judge the viability of a given location, where to open or reposition stores or how to price a certain piece of property.

NEERA has now been acquired by Fetch Capital Partners for an unspecified amount with no indicators.

The platform was built in 2016 while co-founders Joyeeta Das and David Kell were studying at Oxford University. After forming Gyana with other alumni and business partners, the NEERA platform went to market in 2017, making an immediate impact. Gyana acquired an impressive roster of clients by 2019, including Barclays, Pret a Manger, McKinsey, BCG, EY, PwC, UK Ministry of Defense, Colliers, Ellandi, Knight Frank, Realty Income, Vodafone, and others.


Read More: Gyana: The future of data science is codeless


Speaking of the sale, the company said: “It was a rollercoaster ride to figure out the proptech market, and we enjoyed the incredible exposure along the way, winning several awards, such as EG Investment Award for Technology, MSDUK Innovation Challenge Top 3 Disruptive Startups, and Mayor of London’s TechInvest Top 10 AI Startups in London. Exiting early was a pleasant surprise. The capital will provide the company with a more stable footing and higher valuation going forward.”

Gyana will now turn their attention to their latest innovative platform, VAYU, an application that enables any person or business to perform complex data science tasks regardless of talent or budget. VAYU removes the need for programming languages, using an intuitive graphical user interface and sophisticated, AI-powered drag and drop functions instead, to facilitate data insight and clarity. 

The company said: “Most founders like to exit the team and the brand but we kept both to launch our next platform, which has already garnered much success. Our user base is fast-growing, and we’re now busy rolling out new features and functions to satisfy the thousands who choose VAYU for their data discovery needs.”

Fetch Capital Partners said: “It’s a fantastic opportunity to build on an already impressive product and we are excited to grow the platform locally and abroad with an experienced management team together with support from Joyeeta and her team.” CEO and Co-founder Joyeeta Das said: “We are thrilled to partner with such progressive partners, but it’s a bittersweet feeling to part with something you create. We’re very excited to see our product NEERA find a great home. Fetch Analytics will take it to global corners I am sure. We are now focused on our next endeavour, VAYU.”


Bekki Barnes

With 5 years’ experience in marketing, Bekki has knowledge in both B2B and B2C marketing. Bekki has worked with a wide range of brands, including local and national organisations.

The Future of Smart Buildings: Trends in Occupancy Monitoring

Khai Zin Thein • 12th June 2024

Occupancy monitoring technology is revolutionising building management with advancements in AI and IoT. AI algorithms analyse data from IoT sensors, enabling automated adjustments in lighting, HVAC, and security systems based on occupancy levels. Modern systems leverage big data and AI to optimise space usage and resource management, reducing energy consumption and promoting sustainability. Enhanced encryption...

The need to weave agility throughout the business

John Craig Swartz SVP at POWWR • 11th June 2024

With geopolitical tensions, more extreme weather events and the legacy of a global pandemic, it is more difficult for energy suppliers to preserve their margins and remain competitive than ever before. To thrive in the current climate, it is imperative that a supplier makes marginal gains wherever they can. Profitability within the sector today hinges...

Artificial general intelligence is closer than expected

AI expert Stuart Fenton • 10th June 2024

Whilst most of the attention around artificial intelligence (AI) thus far has been on ChatGPT, it is just the tip of the iceberg. In many ways, ChatGPT shouldn’t be thought of as true AI as it is – at its heart – just generative, learned behaviour. The future of AI, in contrast, is a system...

The State of Data Streaming

Confluent • 06th June 2024

Confluent survey: 90% of respondents say data streaming platforms can lead to more product and service innovation in AI and ML development 86% of respondents cite data streaming as a strategic or important priority for IT investments in 2024 For 91% of respondents, data streaming platforms are critical or important for achieving data-related goals

The State of Data Streaming

Confluent • 06th June 2024

Confluent survey: 90% of respondents say data streaming platforms can lead to more product and service innovation in AI and ML development 86% of respondents cite data streaming as a strategic or important priority for IT investments in 2024 For 91% of respondents, data streaming platforms are critical or important for achieving data-related goals

Grant Funding Awarded to Advance Cancer Therapeutics Discovery

Dr Alan Roth • 04th June 2024

The CRUK (Cancer Research UK) Scotland Institute and Oxford Drug Design, a biotechnology company with core expertise in AI drug discovery, have announced that their joint application for the MRC (UK Medical Research Council) National Mouse Genetics Network (NMGN) Business Engagement Fund has been awarded.

Grant Funding Awarded to Advance Cancer Therapeutics Discovery

Dr Alan Roth • 04th June 2024

The CRUK (Cancer Research UK) Scotland Institute and Oxford Drug Design, a biotechnology company with core expertise in AI drug discovery, have announced that their joint application for the MRC (UK Medical Research Council) National Mouse Genetics Network (NMGN) Business Engagement Fund has been awarded.